REUTERS - Drugmaker Glenmark Pharmaceuticals Ltd (GLEN.NS) said on Thursday its European unit had launched a generic version of GlaxoSmithKline's (GSK.L) Malarone malaria treatment medicine, its first generic product in Britain.
Glenmark launched the drug after the revocation of Glaxo's patent on Malarone by the High Court in Britain, the Indian company said in a statement, adding the medicine had sales of $28 million in the year ended September.
(Reporting by Sumeet Chatterjee in MUMBAI; editing by Jane Baird)
Trending On Reuters
A Turkish Airlines flight from Bangkok made an emergency landing in New Delhi after a written bomb threat was found in a toilet on the Airbus A330 passenger jet carrying 134 passengers, the airline and Indian security sources said. Full Article
Insight - Car dashboards that act like smart phones raise safety issues Full Article